SlideShare a Scribd company logo
HUMAN IMMUNO DEFICIENCY
VIRUS
14-11-22
 https://youtu.be/odRyv7V8LAE
 Human Immunodeficiency Virus (HIV)- virus
that primarily infects cells of the immune
system and that causes AIDS
 Acquired Immune Deficiency Syndrome
(AIDS)- disease that is caused by HIV
infection, which weakens the immune system
 Pandemic- disease that spreads quickly
through human populations all over the world
HIV
 “Human Immunodeficiency Virus”
 A specific type of virus (a retrovirus)
 HIV invades the helper T cells to
replicate itself.
Modes of HIV/AIDS
Transmission
AIDS
 Acquired Immunodeficiency Syndrome
 HIV is the virus that causes AIDS
 Disease limits the body’s ability to fight
infection
 A person with AIDS has a very weak
immune system
Chapter 21.2 Key Terms
 Helper T Cell- white blood cell that activates
the immune response and that is the primary
target cell of HIV infection
 Opportunistic Infection- illness due to an
organism that causes disease in people with
weakened immune systems; commonly found
in AIDS patients
 Asymptomatic stage- infection in which the
infectious agent, such as HIV, is present but
there are few or no symptoms of the infection
 HIV uses CD4 immune
cells to replicate. And
each infected CD4 cell
produces hundreds of
new copies of new
HIV particles. The
process is called the
HIV lifecycle. Each
replication cycle only
lasts 1 to 2 days.
 When viruses reproduce it
is called replication. HIV
uses CD4 immune cells to
replicate. And each
infected CD4 cell produces
hundreds of new copies of
new HIV particles.
Three Phases of HIV
Phase 1- Asymptomatic Stage
 Short, flu-like illness, swollen glands, fatigue,
diarrhea, weight loss, or fevers - occurs one to six
weeks after infection
 no symptoms at all
 Infected person can infect other people
 Lasts for an average of ten years
 HIV antibodies are detectable in the blood
Phase 2 - Symptomatic
 The symptoms worsen
Phase 3 - HIV  AIDS
 Immune system
weakens
 Emergence of
opportunistic
infections
 The illnesses
become more severe
leading to an AIDS
diagnosis
Opportunistic Infections
associated with AIDS
 Bacterial
 Tuberculosis (TB)
 Pneumocystis
pneumonia
 Viral
 Kaposi Sarcoma-
purple-red blotches
on the skin
 Influenza (flu)
 The seven stages of the HIV life cycle
are: 1) binding, 2) fusion, 3)
reverse transcription, 4)
integration, 5) replication, 6)
assembly, and 7) budding.
 HIV uses CD4 immune cells to replicate.
And each infected CD4 cell produces
hundreds of new copies of new HIV
particles. The process is called the HIV
lifecycle. Each replication cycle only
lasts 1 to 2 days.
Through Bodily Fluids
 Blood products
 Semen
 Vaginal fluids
 Breast Milk
 The new double-stranded HIV can now
be integrated into human DNA. Drugs
that block this process are called
integrase inhibitors, abbreviated to INIs
or INSTIs.
 The CD4 nucleus then starts producing
raw material to make new HIV. These
long strands of new HIV particles need
to be cut up and assembled as new
virus. The enzyme involved in the
cutting and assembling process is called
protease. The HIV meds that block this
process are called protease inhibitors.
 a fter HIV attaches to the CD4 cell, it is
absorbed into the main body of the cell. As
this happens, HIV first loses its outer shell.
This leaves viral capsid with HIV and three
key enzymes (a type of protein) that HIV
uses to replicate. The capsid releases its
contents into the cell nucleus.

 These enzymes then work in the nucleus.
The first enzyme is called RT. This stands for
reverse transcriptase. RT changes the single
strand of HIV (called RNA) into a double
strand to fit in with human DNA. Two
different types of RT inhibitors (RTIs) block
this process: (i) nucleoside/tide
(NRTIs/NtRTIs), and (ii) non-nucleoside
(NNRTIs).
Through IV Drug Use
 Sharing Needles
 Without sterilization
 Increases the chances of contracting HIV
Through Sex
 Intercourse (penile penetration into the
vagina)
 Oral
 Anal
 Digital Sex
Mother-to-Baby
 Before Birth
 During Birth
 Postpartum
 After the birth
Chapter 21.3 Key Terms
 Universal Precautions- set of procedures used
to avoid contact with body fluids & to reduce
the risk of spreading HIV & other diseases
 HIV-antibody test- detects HIV antibodies to
determine if a person has been infected with
HIV
 HIV Positive- person who tests positive in 2
different HIV tests
 Drug Combination Therapy- AIDS treatment
program in which patients regularly take
more than one drug
Testing Options for HIV
Anonymous Testing
 -consent
 Unique identifying number
 Results issued only to test recipient
23659874515
Anonymous
Confidential Testing
 Results issued only to test recipient
 If positive-trating doctor
 Counselling.
T cell count test
 Shows the strength of a patient’s
immune system
 This test can also tell whether a person
has developed AIDS
Viral load test
 Measures of the number of viruses in
the blood
 The higher the viral load, the more
infectious the person’s body fluids are
likely to be and the closer that person is
to having AIDS
 Card test-serology
 Western blot-
confirmatory.
Retest
 Should be retested 6 months after the
first test
 An initial negative test can be
misleading if the test is done too soon
after infection
Treatment Options
 newly formed virus then has to leave
the cell.
 Budding inhibitors stop new HIV
from leaving of the CD4 cell.
 Maturation inhibitors block the final
assembly process.
 The newly released viruses (called
virions) go on to infect new CD4 cells –
to repeat the process over again. The
old CD4 cell then dies. This continuous
process happens millions of times every
day when not on ART. Without ART, HIV
is one of the most active and rapidly
reproducing virus.
Abbreviation Full names
NRTIs/NtRTIs
(“nukes”)
Nucleoside/tide reverse transcriptase inhibitors or
nucleoside/tide analogues.
NNRTIs (“non-
nukes”)
Non-nucleoside reverse transcriptase inhibitors.
PIs Protease inhibitors.
INIs (or INSTIs) Integrase (strand transfer) inhibitors.
CCR5 inhibitors CCR5 inhibitors are a type of entry inhibitor.
Fusion inhibitors Fusion inhibitors are a type of entry inhibitor.
mAbs Monoclonal antibodies block HIV entering the T-cell.
CIs (?) Capsid inhibitors.
L
WESTERN BLOT
HIV CLASS-22 BATCH.ppt
HIV CLASS-22 BATCH.ppt
HIV CLASS-22 BATCH.ppt

More Related Content

Similar to HIV CLASS-22 BATCH.ppt

HIV and AIDS
HIV and AIDSHIV and AIDS
HIV and AIDS
Gabrielle Barnes
 
Hiv aids lecture
Hiv aids lectureHiv aids lecture
Hiv aids lecture
TeamPulaw
 
Epidemiology of hiv
Epidemiology of hivEpidemiology of hiv
Epidemiology of hiv
Shashikant Pawar
 
AIDS (HIV INFECTION) & ART (M. PHARM PHARMACOLOGY SEM-III)
AIDS (HIV INFECTION) & ART (M. PHARM PHARMACOLOGY SEM-III)AIDS (HIV INFECTION) & ART (M. PHARM PHARMACOLOGY SEM-III)
AIDS (HIV INFECTION) & ART (M. PHARM PHARMACOLOGY SEM-III)
S.G.S.S. COLLEGE OF PHARMACY, MANUR
 
NPF: AIDS 2010 Refresher for Vienna Journalists
NPF: AIDS 2010 Refresher for Vienna JournalistsNPF: AIDS 2010 Refresher for Vienna Journalists
NPF: AIDS 2010 Refresher for Vienna JournalistsDaric Snyder
 
Aids
AidsAids
Hiv infection
Hiv  infectionHiv  infection
Hiv infection
MuhammadAbbaskhan9
 
AIDs.pptx
AIDs.pptxAIDs.pptx
AIDs.pptx
Sairanaz20
 
immunological disorders.pptx
immunological disorders.pptximmunological disorders.pptx
immunological disorders.pptx
SidraHameed25
 
Microbiology hiv-yf
Microbiology   hiv-yfMicrobiology   hiv-yf
Microbiology hiv-yfMBBS IMS MSU
 
HIV infection. HIV-associated related opportunistic infections and invasions
HIV infection. HIV-associated related opportunistic infections and invasionsHIV infection. HIV-associated related opportunistic infections and invasions
HIV infection. HIV-associated related opportunistic infections and invasions
Aniuta Sydorchuk
 
HIV & AIDs.pptx
HIV & AIDs.pptxHIV & AIDs.pptx
HIV & AIDs.pptx
Amjad Afridi
 
Aids and hepatits
Aids and hepatitsAids and hepatits
Aids and hepatits
DR DAVIS NADAKKAVUKARAN
 
STI, HIV and AIDS
STI, HIV and AIDSSTI, HIV and AIDS
STI, HIV and AIDS
GENY DIAZ
 
Aids
AidsAids
Aids
plokee
 
Hiv interaction , microbiology pdf for virus
Hiv interaction , microbiology pdf for virusHiv interaction , microbiology pdf for virus
Hiv interaction , microbiology pdf for virus
honeyhada18
 
Rimsha Shafiq
Rimsha Shafiq Rimsha Shafiq
Rimsha Shafiq
RimshaShafeeq1
 
Hiv Pre by pooja
Hiv Pre by poojaHiv Pre by pooja
Hiv Pre by pooja
rohal
 

Similar to HIV CLASS-22 BATCH.ppt (20)

HIV and AIDS
HIV and AIDSHIV and AIDS
HIV and AIDS
 
Hiv aids lecture
Hiv aids lectureHiv aids lecture
Hiv aids lecture
 
Epidemiology of hiv
Epidemiology of hivEpidemiology of hiv
Epidemiology of hiv
 
AIDS (HIV INFECTION) & ART (M. PHARM PHARMACOLOGY SEM-III)
AIDS (HIV INFECTION) & ART (M. PHARM PHARMACOLOGY SEM-III)AIDS (HIV INFECTION) & ART (M. PHARM PHARMACOLOGY SEM-III)
AIDS (HIV INFECTION) & ART (M. PHARM PHARMACOLOGY SEM-III)
 
NPF: AIDS 2010 Refresher for Vienna Journalists
NPF: AIDS 2010 Refresher for Vienna JournalistsNPF: AIDS 2010 Refresher for Vienna Journalists
NPF: AIDS 2010 Refresher for Vienna Journalists
 
HIV/AIDS (IMMUNOLOGY)
HIV/AIDS (IMMUNOLOGY)HIV/AIDS (IMMUNOLOGY)
HIV/AIDS (IMMUNOLOGY)
 
Aids
AidsAids
Aids
 
Hiv infection
Hiv  infectionHiv  infection
Hiv infection
 
AIDs.pptx
AIDs.pptxAIDs.pptx
AIDs.pptx
 
immunological disorders.pptx
immunological disorders.pptximmunological disorders.pptx
immunological disorders.pptx
 
Microbiology hiv-yf
Microbiology   hiv-yfMicrobiology   hiv-yf
Microbiology hiv-yf
 
HIV infection. HIV-associated related opportunistic infections and invasions
HIV infection. HIV-associated related opportunistic infections and invasionsHIV infection. HIV-associated related opportunistic infections and invasions
HIV infection. HIV-associated related opportunistic infections and invasions
 
HIV & AIDs.pptx
HIV & AIDs.pptxHIV & AIDs.pptx
HIV & AIDs.pptx
 
Aids and hepatits
Aids and hepatitsAids and hepatits
Aids and hepatits
 
STI, HIV and AIDS
STI, HIV and AIDSSTI, HIV and AIDS
STI, HIV and AIDS
 
Aids
AidsAids
Aids
 
AIDS
AIDSAIDS
AIDS
 
Hiv interaction , microbiology pdf for virus
Hiv interaction , microbiology pdf for virusHiv interaction , microbiology pdf for virus
Hiv interaction , microbiology pdf for virus
 
Rimsha Shafiq
Rimsha Shafiq Rimsha Shafiq
Rimsha Shafiq
 
Hiv Pre by pooja
Hiv Pre by poojaHiv Pre by pooja
Hiv Pre by pooja
 

More from Arunaveeruswamy

INTERNET OF MEDICAL THING.DEVICES TO MONITOR PATIENTS.
INTERNET OF MEDICAL THING.DEVICES TO MONITOR PATIENTS.INTERNET OF MEDICAL THING.DEVICES TO MONITOR PATIENTS.
INTERNET OF MEDICAL THING.DEVICES TO MONITOR PATIENTS.
Arunaveeruswamy
 
bench marking in detail in health care industry
bench marking in detail in health care  industrybench marking in detail in health care  industry
bench marking in detail in health care industry
Arunaveeruswamy
 
qulaity circle New Microsoft Office PowerPoint Presentation.pptx
qulaity circle New Microsoft Office PowerPoint Presentation.pptxqulaity circle New Microsoft Office PowerPoint Presentation.pptx
qulaity circle New Microsoft Office PowerPoint Presentation.pptx
Arunaveeruswamy
 
xenobiotic metabolism, detoxification of drugs, enzyme action
xenobiotic metabolism, detoxification of  drugs, enzyme actionxenobiotic metabolism, detoxification of  drugs, enzyme action
xenobiotic metabolism, detoxification of drugs, enzyme action
Arunaveeruswamy
 
Acid base balance class-1.pptx
Acid base balance class-1.pptxAcid base balance class-1.pptx
Acid base balance class-1.pptx
Arunaveeruswamy
 
DNA REPAIR-2.pdf
DNA REPAIR-2.pdfDNA REPAIR-2.pdf
DNA REPAIR-2.pdf
Arunaveeruswamy
 
13-miller-chap-21-lecture.ppt
13-miller-chap-21-lecture.ppt13-miller-chap-21-lecture.ppt
13-miller-chap-21-lecture.ppt
Arunaveeruswamy
 
clinical audit
clinical auditclinical audit
clinical audit
Arunaveeruswamy
 
dietary fibre.ppt
dietary fibre.pptdietary fibre.ppt
dietary fibre.ppt
Arunaveeruswamy
 
dietary fat.ppt
dietary fat.pptdietary fat.ppt
dietary fat.ppt
Arunaveeruswamy
 
GALACTOSE AND FRUCTOSE(2).pptx
GALACTOSE AND FRUCTOSE(2).pptxGALACTOSE AND FRUCTOSE(2).pptx
GALACTOSE AND FRUCTOSE(2).pptx
Arunaveeruswamy
 
Replication & repair 504.pptx
Replication & repair 504.pptxReplication & repair 504.pptx
Replication & repair 504.pptx
Arunaveeruswamy
 
DNA REPAIR-2(1).pptx
DNA REPAIR-2(1).pptxDNA REPAIR-2(1).pptx
DNA REPAIR-2(1).pptx
Arunaveeruswamy
 
fatty-oxidation-MBBS.ppt
fatty-oxidation-MBBS.pptfatty-oxidation-MBBS.ppt
fatty-oxidation-MBBS.ppt
Arunaveeruswamy
 

More from Arunaveeruswamy (14)

INTERNET OF MEDICAL THING.DEVICES TO MONITOR PATIENTS.
INTERNET OF MEDICAL THING.DEVICES TO MONITOR PATIENTS.INTERNET OF MEDICAL THING.DEVICES TO MONITOR PATIENTS.
INTERNET OF MEDICAL THING.DEVICES TO MONITOR PATIENTS.
 
bench marking in detail in health care industry
bench marking in detail in health care  industrybench marking in detail in health care  industry
bench marking in detail in health care industry
 
qulaity circle New Microsoft Office PowerPoint Presentation.pptx
qulaity circle New Microsoft Office PowerPoint Presentation.pptxqulaity circle New Microsoft Office PowerPoint Presentation.pptx
qulaity circle New Microsoft Office PowerPoint Presentation.pptx
 
xenobiotic metabolism, detoxification of drugs, enzyme action
xenobiotic metabolism, detoxification of  drugs, enzyme actionxenobiotic metabolism, detoxification of  drugs, enzyme action
xenobiotic metabolism, detoxification of drugs, enzyme action
 
Acid base balance class-1.pptx
Acid base balance class-1.pptxAcid base balance class-1.pptx
Acid base balance class-1.pptx
 
DNA REPAIR-2.pdf
DNA REPAIR-2.pdfDNA REPAIR-2.pdf
DNA REPAIR-2.pdf
 
13-miller-chap-21-lecture.ppt
13-miller-chap-21-lecture.ppt13-miller-chap-21-lecture.ppt
13-miller-chap-21-lecture.ppt
 
clinical audit
clinical auditclinical audit
clinical audit
 
dietary fibre.ppt
dietary fibre.pptdietary fibre.ppt
dietary fibre.ppt
 
dietary fat.ppt
dietary fat.pptdietary fat.ppt
dietary fat.ppt
 
GALACTOSE AND FRUCTOSE(2).pptx
GALACTOSE AND FRUCTOSE(2).pptxGALACTOSE AND FRUCTOSE(2).pptx
GALACTOSE AND FRUCTOSE(2).pptx
 
Replication & repair 504.pptx
Replication & repair 504.pptxReplication & repair 504.pptx
Replication & repair 504.pptx
 
DNA REPAIR-2(1).pptx
DNA REPAIR-2(1).pptxDNA REPAIR-2(1).pptx
DNA REPAIR-2(1).pptx
 
fatty-oxidation-MBBS.ppt
fatty-oxidation-MBBS.pptfatty-oxidation-MBBS.ppt
fatty-oxidation-MBBS.ppt
 

Recently uploaded

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Antimicrobial stewardship to prevent antimicrobial resistance
Antimicrobial stewardship to prevent antimicrobial resistanceAntimicrobial stewardship to prevent antimicrobial resistance
Antimicrobial stewardship to prevent antimicrobial resistance
GovindRankawat1
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERY
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERYDISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERY
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERY
NEHA GUPTA
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
MGM SCHOOL/COLLEGE OF NURSING
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 

Recently uploaded (20)

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Antimicrobial stewardship to prevent antimicrobial resistance
Antimicrobial stewardship to prevent antimicrobial resistanceAntimicrobial stewardship to prevent antimicrobial resistance
Antimicrobial stewardship to prevent antimicrobial resistance
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERY
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERYDISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERY
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERY
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 

HIV CLASS-22 BATCH.ppt

  • 2.
  • 3.
  • 4.
  • 6.
  • 7.  Human Immunodeficiency Virus (HIV)- virus that primarily infects cells of the immune system and that causes AIDS  Acquired Immune Deficiency Syndrome (AIDS)- disease that is caused by HIV infection, which weakens the immune system  Pandemic- disease that spreads quickly through human populations all over the world
  • 8. HIV  “Human Immunodeficiency Virus”  A specific type of virus (a retrovirus)  HIV invades the helper T cells to replicate itself.
  • 10. AIDS  Acquired Immunodeficiency Syndrome  HIV is the virus that causes AIDS  Disease limits the body’s ability to fight infection  A person with AIDS has a very weak immune system
  • 11. Chapter 21.2 Key Terms  Helper T Cell- white blood cell that activates the immune response and that is the primary target cell of HIV infection  Opportunistic Infection- illness due to an organism that causes disease in people with weakened immune systems; commonly found in AIDS patients  Asymptomatic stage- infection in which the infectious agent, such as HIV, is present but there are few or no symptoms of the infection
  • 12.  HIV uses CD4 immune cells to replicate. And each infected CD4 cell produces hundreds of new copies of new HIV particles. The process is called the HIV lifecycle. Each replication cycle only lasts 1 to 2 days.
  • 13.  When viruses reproduce it is called replication. HIV uses CD4 immune cells to replicate. And each infected CD4 cell produces hundreds of new copies of new HIV particles.
  • 15. Phase 1- Asymptomatic Stage  Short, flu-like illness, swollen glands, fatigue, diarrhea, weight loss, or fevers - occurs one to six weeks after infection  no symptoms at all  Infected person can infect other people  Lasts for an average of ten years  HIV antibodies are detectable in the blood
  • 16. Phase 2 - Symptomatic  The symptoms worsen
  • 17. Phase 3 - HIV  AIDS  Immune system weakens  Emergence of opportunistic infections  The illnesses become more severe leading to an AIDS diagnosis
  • 18. Opportunistic Infections associated with AIDS  Bacterial  Tuberculosis (TB)  Pneumocystis pneumonia  Viral  Kaposi Sarcoma- purple-red blotches on the skin  Influenza (flu)
  • 19.  The seven stages of the HIV life cycle are: 1) binding, 2) fusion, 3) reverse transcription, 4) integration, 5) replication, 6) assembly, and 7) budding.
  • 20.  HIV uses CD4 immune cells to replicate. And each infected CD4 cell produces hundreds of new copies of new HIV particles. The process is called the HIV lifecycle. Each replication cycle only lasts 1 to 2 days.
  • 21. Through Bodily Fluids  Blood products  Semen  Vaginal fluids  Breast Milk
  • 22.  The new double-stranded HIV can now be integrated into human DNA. Drugs that block this process are called integrase inhibitors, abbreviated to INIs or INSTIs.
  • 23.  The CD4 nucleus then starts producing raw material to make new HIV. These long strands of new HIV particles need to be cut up and assembled as new virus. The enzyme involved in the cutting and assembling process is called protease. The HIV meds that block this process are called protease inhibitors.
  • 24.
  • 25.  a fter HIV attaches to the CD4 cell, it is absorbed into the main body of the cell. As this happens, HIV first loses its outer shell. This leaves viral capsid with HIV and three key enzymes (a type of protein) that HIV uses to replicate. The capsid releases its contents into the cell nucleus. 
  • 26.  These enzymes then work in the nucleus. The first enzyme is called RT. This stands for reverse transcriptase. RT changes the single strand of HIV (called RNA) into a double strand to fit in with human DNA. Two different types of RT inhibitors (RTIs) block this process: (i) nucleoside/tide (NRTIs/NtRTIs), and (ii) non-nucleoside (NNRTIs).
  • 27. Through IV Drug Use  Sharing Needles  Without sterilization  Increases the chances of contracting HIV
  • 28. Through Sex  Intercourse (penile penetration into the vagina)  Oral  Anal  Digital Sex
  • 29. Mother-to-Baby  Before Birth  During Birth  Postpartum  After the birth
  • 30. Chapter 21.3 Key Terms  Universal Precautions- set of procedures used to avoid contact with body fluids & to reduce the risk of spreading HIV & other diseases  HIV-antibody test- detects HIV antibodies to determine if a person has been infected with HIV  HIV Positive- person who tests positive in 2 different HIV tests  Drug Combination Therapy- AIDS treatment program in which patients regularly take more than one drug
  • 32. Anonymous Testing  -consent  Unique identifying number  Results issued only to test recipient 23659874515 Anonymous
  • 33. Confidential Testing  Results issued only to test recipient  If positive-trating doctor  Counselling.
  • 34. T cell count test  Shows the strength of a patient’s immune system  This test can also tell whether a person has developed AIDS
  • 35. Viral load test  Measures of the number of viruses in the blood  The higher the viral load, the more infectious the person’s body fluids are likely to be and the closer that person is to having AIDS
  • 36.  Card test-serology  Western blot- confirmatory.
  • 37. Retest  Should be retested 6 months after the first test  An initial negative test can be misleading if the test is done too soon after infection
  • 38.
  • 40.  newly formed virus then has to leave the cell.  Budding inhibitors stop new HIV from leaving of the CD4 cell.  Maturation inhibitors block the final assembly process.
  • 41.  The newly released viruses (called virions) go on to infect new CD4 cells – to repeat the process over again. The old CD4 cell then dies. This continuous process happens millions of times every day when not on ART. Without ART, HIV is one of the most active and rapidly reproducing virus.
  • 42. Abbreviation Full names NRTIs/NtRTIs (“nukes”) Nucleoside/tide reverse transcriptase inhibitors or nucleoside/tide analogues. NNRTIs (“non- nukes”) Non-nucleoside reverse transcriptase inhibitors. PIs Protease inhibitors. INIs (or INSTIs) Integrase (strand transfer) inhibitors. CCR5 inhibitors CCR5 inhibitors are a type of entry inhibitor. Fusion inhibitors Fusion inhibitors are a type of entry inhibitor. mAbs Monoclonal antibodies block HIV entering the T-cell. CIs (?) Capsid inhibitors. L
  • 43.
  • 44.
  • 45.
  • 46.
  • 47.
  • 48.